Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:ATC_code
|
| gptkbp:affiliatedWith |
ATC code B (Blood and blood forming organs)
|
| gptkbp:hasSubgroup |
B01A (Antithrombotic agents)
B01AA (Vitamin K antagonists) B01AB (Heparin group) B01AD (Enzymes) B01AE (Direct thrombin inhibitors) B01AF (Direct factor Xa inhibitors) B01AC (Platelet aggregation inhibitors excluding heparin) |
| https://www.w3.org/2000/01/rdf-schema#label |
B01 (Antithrombotic agents)
|
| gptkbp:includesDrug |
gptkb:warfarin
gptkb:rivaroxaban gptkb:apixaban gptkb:heparin gptkb:clopidogrel gptkb:alteplase gptkb:aspirin gptkb:dabigatran |
| gptkbp:partOf |
gptkb:Anatomical_Therapeutic_Chemical_Classification_System
|
| gptkbp:regulates |
blood coagulation
platelet aggregation |
| gptkbp:therapeuticArea |
cardiology
hematology |
| gptkbp:usedFor |
prevention of thrombosis
treatment of thrombosis |
| gptkbp:bfsParent |
gptkb:B01AF01
|
| gptkbp:bfsLayer |
7
|